Research Highlights

Research Highlights 04-2000

Diane G. Cope

cancer research

Two separate studies have found promising results in combination Rituxan/CHOP chemotherapy for patients with non-Hodgkin lymphoma (NHL). Researchers from Roswell Park Memorial Institute reported three-year follow-up data in patients with low-grade or follicular NHL who received combination regimens.

  • Combination Rituxan/CHOP Chemotherapy for NHL Provides Prolonged Response Rates
  • Rituxan Shows improved Response in Chronic Lymphocytic Leukemia
  • Rituxan Shows Activity Against Multiple Myeloma
  • New Antibody Therapy Provides Remission in Some Patients With AML
  • Rituxan Shown to increase Responses in Non-Hodgkin’s
  • Lymphoma Adriamycin/Taxol Combination Shows Superiority Over FAC in Metastatic Breast Cancer
  • Weekly Combination Paclitaxel/Herceptin Therapy Effective in Metastatic Breast Cancer
  • Goserelin/Tamoxifen Reduces Recurrences in Premenopausal Patients With Breast Cancer
  • Weekly High-Dose Neoadjuvant Paclitaxel Effective in Advanced-Stage Breast Cancer
  • Anastfozoie Is as Effective as Tamoxifen for First-Line Therapy in Metastatic Breast Cancer
Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.